Authors: Lopez-Aguilar, E Sepulveda-Vildosola, AC Rivera-Marquez, H Cerecedo-Diaz, F Hernandez-Contreras, I Ramon-Garcia, G Diegoperez-Ramirez, J Santacruz-Castillo, E

Citation: E. Lopez-aguilar et al., Preirradiation ifosfamide, carboplatin, and etoposide for the treatment ofanaplastic astrocytomas and glioblastoma multiforme: A phase II study, ARCH MED R, 31(2), 2000, pp. 186-190

Authors: Lopez-Aguilar, E Sepulveda-Vildosola, AC Rivera-Marquez, H Cerecedo-Diaz, F Valdez-Sanchez, M Villasis-Keever, MA

Citation: E. Lopez-aguilar et al., Security and maximal tolerated doses of fluvastatin in pediatric cancer patients, ARCH MED R, 30(2), 1999, pp. 128-131

Authors: Lopez-Aguilar, E Sepulveda-Vildosola, AC Rivera-Marquez, H Cerecedo-Diaz, F Santacruz-Castillo, E Valdez-Sanchez, M Arias-Gomez, J Quintana-Roldan, G

Citation: E. Lopez-aguilar et al., Survival of patients with medulloblastoma treated with carboplatin and etoposide before and after radiotherapy, ARCH MED R, 29(4), 1998, pp. 313-317